Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 2
1999 1
2000 2
2001 1
2002 2
2003 3
2004 2
2005 1
2006 6
2007 2
2008 12
2009 12
2010 13
2011 16
2012 10
2013 11
2014 13
2015 13
2016 8
2017 12
2018 12
2019 9
2020 7
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

158 results
Results by year
Filters applied: . Clear all
Page 1
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
Nemes E, Geldenhuys H, Rozot V, Rutkowski KT, Ratangee F, Bilek N, Mabwe S, Makhethe L, Erasmus M, Toefy A, Mulenga H, Hanekom WA, Self SG, Bekker LG, Ryall R, Gurunathan S, DiazGranados CA, Andersen P, Kromann I, Evans T, Ellis RD, Landry B, Hokey DA, Hopkins R, Ginsberg AM, Scriba TJ, Hatherill M; C-040-404 Study Team. Nemes E, et al. Among authors: hanekom wa. N Engl J Med. 2018 Jul 12;379(2):138-149. doi: 10.1056/NEJMoa1714021. N Engl J Med. 2018. PMID: 29996082 Free PMC article. Clinical Trial.
A blood RNA signature for tuberculosis disease risk: a prospective cohort study.
Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, Mahomed H, Erasmus M, Whatney W, Hussey GD, Abrahams D, Kafaar F, Hawkridge T, Verver S, Hughes EJ, Ota M, Sutherland J, Howe R, Dockrell HM, Boom WH, Thiel B, Ottenhoff THM, Mayanja-Kizza H, Crampin AC, Downing K, Hatherill M, Valvo J, Shankar S, Parida SK, Kaufmann SHE, Walzl G, Aderem A, Hanekom WA; ACS and GC6-74 cohort study groups. Zak DE, et al. Among authors: hanekom wa. Lancet. 2016 Jun 4;387(10035):2312-2322. doi: 10.1016/S0140-6736(15)01316-1. Epub 2016 Mar 24. Lancet. 2016. PMID: 27017310 Free PMC article.
H1:IC31 vaccination is safe and induces long-lived TNF-α+IL-2+CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial.
Mearns H, Geldenhuys HD, Kagina BM, Musvosvi M, Little F, Ratangee F, Mahomed H, Hanekom WA, Hoff ST, Ruhwald M, Kromann I, Bang P, Hatherill M, Andersen P, Scriba TJ; THYB04 study group. Mearns H, et al. Among authors: hanekom wa. Vaccine. 2017 Jan 3;35(1):132-141. doi: 10.1016/j.vaccine.2016.11.023. Epub 2016 Nov 18. Vaccine. 2017. PMID: 27866772 Clinical Trial.
Tuberculosis research update.
Hanekom WA, Lawn SD, Dheda K, Whitelaw A. Hanekom WA, et al. Trop Med Int Health. 2010 Aug;15(8):981-9. doi: 10.1111/j.1365-3156.2010.02568.x. Epub 2010 Jun 15. Trop Med Int Health. 2010. PMID: 20561306 Free article. Review.
New hope for tuberculosis vaccines.
Olesen OF, Abdullah F, Coppens R, Gardner PJ, Ginsberg AM, Hanekom WA, Laang H, Lewinsohn DM, Loots G, Schmidt A, Vekemans J, Voss GH. Olesen OF, et al. Among authors: hanekom wa. Lancet Infect Dis. 2019 Jul;19(7):687-688. doi: 10.1016/S1473-3099(19)30280-4. Lancet Infect Dis. 2019. PMID: 31250810 No abstract available.
Immunological protection against tuberculosis.
Hanekom WA, Abel B, Scriba TJ. Hanekom WA, et al. S Afr Med J. 2007 Oct;97(10 Pt 2):973-7. S Afr Med J. 2007. PMID: 18000583 Review. No abstract available.
New vaccines against tuberculosis.
Lambert PH, Hawkridge T, Hanekom WA. Lambert PH, et al. Among authors: hanekom wa. Clin Chest Med. 2009 Dec;30(4):811-26, x. doi: 10.1016/j.ccm.2009.08.014. Clin Chest Med. 2009. PMID: 19925969 Review.
158 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page